Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women

15 hours ago 5

The FDA appears to be slow-walking its mifepristone review, frustrating Trump allies in both Congress and pro-life states.

1. Homepage
2. Politics
3. Despite Promise To Be Pro-Life ‘Ally,’ Trump Admin Won’t Regulate Abortion Drug Endangering Women